Virtus Biotech Clinical Trials ETF (BBC) — ETF Analysis on Winston

Key Facts

• Issuer: Virtus
• Category: Equity
• Asset Class: Sector Equity
• Price: $51.20
• Expense Ratio: 65.00%
• Assets Under Management: $47M
• Number of Holdings: 198
• Inception Date: 2014-12-16
• Currency: USD

Winston Score

Virtus Biotech Clinical Trials ETF has a Winston Score of 62 out of 100.

Performance

• 1-Year Return: 147.58%
• 3-Year Return: 102.33%
• 5-Year Return: -11.36%

Top Holdings

Erasca Inc (N/A%), Rezolute Inc (N/A%), Tango Therapeutics Inc (N/A%), Spyre Therapeutics Inc (N/A%), Enliven Therapeutics Inc (N/A%)

Sector Breakdown

Cash & Others (N/A%), Financial Services (N/A%), Healthcare (N/A%)